[The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
Uhnoo
Ingrid
I
Infektionsklioniken, Akademiska sjukhuset, Uppsala. ingrid.uhnoo@mpa.se
Bergquist
Charlotta
C
D000998:Antiviral Agents / Q000008:administration & dosage; D003140:Communicable Disease Control; D004196:Disease Outbreaks / Q000517:prevention & control*; D024882:Drug Resistance, Viral; D014943:Global Health; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000600:supply & distribution; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D053139:Oseltamivir / Q000008:administration & dosage; D053243:Zanamivir / Q000008:administration & dosage
D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D053243:Zanamivir